🔎 Trials Near Me

Hjem › Autoimmune sygdomme › Michigan

Autoimmune sygdomme kliniske forsøg i Michigan

9 studier for Autoimmune sygdomme søger deltagere på steder i Michigan.

Byer i Michigan

Officiel studietekst (engelsk)

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  • Clinical Research Inst of MI, Saint Clair Shores
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07621809

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

  • University of Michigan, Ann Arbor
RekruttererObservationsstudie
1 Month – 100 Years · Alle køn · Opdateret 24. sep. 2026 · NCT00246857

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of Michigan - Accepting Young Adult and Juvenile Patients, Ann Arbor
RekruttererFase 2/3
Alder 6 til 75 · Alle køn · Opdateret 17. sep. 2026 · NCT06154252

Daratumumab in Primary Antiphospholipid Syndrome

  • University of Michigan, Ann Arbor
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 16. sep. 2026 · NCT05671757

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • University of Michigan, Ann Arbor
RekruttererFase 2/3
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT06328777

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1026, Detroit
  • Site Number - 1005, East Lansing
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 30. jul. 2026 · NCT07039916

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Michigan, Ann Arbor
  • Children's Hospital of Michigan, Detroit
  • Henry Ford Health System, Detroit
  • og 2 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • Karmanos Cancer Institute, Detroit
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT06626919

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.